Literature DB >> 16546166

Candidate tumor suppressor LUCA-15/RBM5/H37 modulates expression of apoptosis and cell cycle genes.

Mirna Mourtada-Maarabouni1, Jennifer Keen, Jeremy Clark, Colin S Cooper, Gwyn T Williams.   

Abstract

RBM5 (RNA-binding motif protein 5/LUCA-15/H37) is encoded at the lung cancer tumor suppressor locus 3p21.3 and itself has several important characteristics of a tumor suppressor, including both potentiation of apoptosis and inhibition of the cell cycle. Here, we report the effects of both upregulation and downregulation of LUCA-15/RBM5 on gene expression monitored using cDNA microarrays. Many of the genes modulated by LUCA-15/RBM5 are involved in the control of apoptosis, the cell cycle, or both. These effects were confirmed for the most significant genes using real-time RT-PCR and/or Western blotting. In particular, LUCA-15/RBM5 increased the expression of Stat5b and BMP5 and decreased the expression of AIB1 (Amplified In Breast Cancer 1), proto-oncogene Pim-1, caspase antagonist BIRC3 (cIAP-2, MIHC), and CDK2 (cyclin-dependent kinase 2). These effects on multiple genes controlling both apoptosis and proliferation are in line with the functional effects of LUCA-15/RBM5 and indicate that it plays a central role in regulating cell fate consistent with its tumor suppressor activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16546166     DOI: 10.1016/j.yexcr.2006.02.009

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  14 in total

1.  Differential downregulation of Rbm5 and Rbm10 during skeletal and cardiac differentiation.

Authors:  Julie J Loiselle; Leslie C Sutherland
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-11-01       Impact factor: 2.416

2.  Whole-transcriptome microarray analysis reveals regulation of Rab4 by RBM5 in neurons.

Authors:  Travis C Jackson; Shawn E Kotermanski; Patrick M Kochanek
Journal:  Neuroscience       Date:  2017-08-15       Impact factor: 3.590

3.  Global expression profiling reveals gain-of-function oncogenic activity of a mutated thyroid hormone receptor in thyroid carcinogenesis.

Authors:  Changxue Lu; Alok Mishra; Yuelin J Zhu; Paul Meltzer; Sheue-Yann Cheng
Journal:  Am J Cancer Res       Date:  2011       Impact factor: 6.166

4.  RNA-binding motif protein 35A is a novel tumor suppressor for colorectal cancer.

Authors:  Olga V Leontieva; Yuri Ionov
Journal:  Cell Cycle       Date:  2009-02-22       Impact factor: 4.534

5.  Identification of Novel Targets of RBM5 in the Healthy and Injured Brain.

Authors:  Travis C Jackson; Keri Janesko-Feldman; Kiersten Gorse; Vincent A Vagni; Edwin K Jackson; Patrick M Kochanek
Journal:  Neuroscience       Date:  2020-04-24       Impact factor: 3.590

Review 6.  The antiapoptotic RBM5/LUCA-15/H37 gene and its role in apoptosis and human cancer: research update.

Authors:  Mirna M Maarabouni; Gwyn T Williams
Journal:  ScientificWorldJournal       Date:  2006-12-28

7.  Lentiviral vector-mediated RBM5 overexpression downregulates EGFR expression in human non-small cell lung cancer cells.

Authors:  Zhenzhong Su; Jinzhi Yin; Lijing Zhao; Ranwei Li; Hong Liang; Jie Zhang; Ke Wang
Journal:  World J Surg Oncol       Date:  2014-12-02       Impact factor: 2.754

8.  Insight into the role of alternative splicing within the RBM10v1 exon 10 tandem donor site.

Authors:  Sarah J Tessier; Julie J Loiselle; Anne McBain; Celine Pullen; Benjamin W Koenderink; Justin G Roy; Leslie C Sutherland
Journal:  BMC Res Notes       Date:  2015-02-19

9.  RBM5 is a male germ cell splicing factor and is required for spermatid differentiation and male fertility.

Authors:  Moira K O'Bryan; Brett J Clark; Eileen A McLaughlin; Rebecca J D'Sylva; Liza O'Donnell; Jacqueline A Wilce; Jessie Sutherland; Anne E O'Connor; Belinda Whittle; Christopher C Goodnow; Christopher J Ormandy; Duangporn Jamsai
Journal:  PLoS Genet       Date:  2013-07-25       Impact factor: 5.917

10.  Loss of the multifunctional RNA-binding protein RBM47 as a source of selectable metastatic traits in breast cancer.

Authors:  Sakari Vanharanta; Christina B Marney; Weiping Shu; Manuel Valiente; Yilong Zou; Aldo Mele; Robert B Darnell; Joan Massagué
Journal:  Elife       Date:  2014-06-04       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.